4 ms·
It seems to me the question is whether the US market fuels investment in research in other countries.
by istjohn 7y ago
It seems to me the question is whether the US market fuels investment in research in other countries.
- AstralStorm 7y agoHow do you propose to measure this? If it's by revenue to the much maligned Big Pharma, then I think not. R&D is a big cost, but not nearly as big in percentage as shown by the pharma companies, so were they all to contract due to sudden existence failure of the USA, they'd still make big profits if they kept the costs the same. The smaller companies would evaporate. I'm basing this on comparing Teva USA vs Teva Global R&D spending data. That is 10% everywhere, 15% in the US (dropping faster) and falling regardless of the USA or not, which is pumping in more money into this company every day. I picked Teva because they're representative and one of global market leaders. https://www.statista.com/statistics/272544/expenditure-on-research-and-development-by-teva-since-2006/ https://www.statista.com/statistics/272544/expenditure-on-re... Solid: https://articles2.marketrealist.com/2018/01/whats-teva-pharmaceuticals-research-development-strategy/ https://articles2.marketrealist.com/2018/01/whats-teva-pharm... (Yes, you can also read their quarterlies for USA branch and other ones. I checked a few.) Decent write-up, if a bit old: https://www.healthaffairs.org/do/10.1377/hblog20170307.059036/full/ https://www.healthaffairs.org/do/10.1377/hblog20170307.05903...